Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Statera Biopharma, Inc. (STAB) had Free Cash Flow per Share of $-0.09 for the most recently reported fiscal quarter, ending 2022-09-30.
| Income Statement Financials | |
$0.67M |
|
$-3.35M |
|
$0.17M |
|
$0.50M |
|
$2.22M |
|
$-1.55M |
|
$-1.81M |
|
$-3.36M |
|
$-3.36M |
|
$-3.36M |
|
$-3.36M |
|
$-3.36M |
|
$-3.36M |
|
$-1.55M |
|
$-1.35M |
|
50.23M |
|
50.23M |
|
$-0.07 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$1.21M |
|
$0.11M |
|
$11.54M |
|
$12.75M |
|
$22.23M |
|
-- |
|
$0.69M |
|
$22.92M |
|
$-10.17M |
|
$-20.68M |
|
$-10.17M |
|
50.74M |
|
| Cash Flow Statement Financials | |
$-4.73M |
|
$-0.01M |
|
$-1.69M |
|
$6.84M |
|
$0.51M |
|
$-6.34M |
|
$-0.90M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.05 |
|
-- |
|
-- |
|
-- |
|
-0.63 |
|
74.74% |
|
-230.65% |
|
-230.65% |
|
-- |
|
-500.68% |
|
-499.47% |
|
$-4.74M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
3.66 |
|
24.62 |
|
33.01% |
|
16.24% |
|
-26.33% |
|
33.01% |
|
$-0.20 |
|
|
Free Cash Flow per Share |
$-0.09 |
$-0.09 |
|